AstraZeneca AZN announced that CHMP has recommended approval for its blockbuster cancer drug Imfinzi (durvalumab) as a monotherapy for treating limited-stage small cell lung cancer (LS-SCLC ...
The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended AstraZeneca's Imfinzi (durvalumab) for approval in the European Union (EU) as a single agent for ...
AstraZeneca, a global, science-led biopharmaceutical company, announced that its Imfinzi (durvalumab) has been recommended for approval in the European Union (EU) as monotherapy for the treatment of ...
The new indication adds to Imfinzi's FDA-approved indications in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), which have helped drive sales of the PD-L1 inhibitor to $1.3 ...
AstraZeneca has revealed the data for Imfinzi in muscle-invasive bladder cancer (MIBC) that it hopes will be enough to secure FDA approval – although the jury is out on that. The clinical ...
2-Year U.S. Treasury Note Continuous Contract $102.695-0.027-0.03% 5-Year U.S. Treasury Note Continuous Contract $106.398-0.063-0.06% 10-Year U.S. Treasury Note Continuous Contract $109.156-0.078 ...
For all those reasons, Berkshire Hathaway is one of the best stocks investors can buy with $500. Prosper Junior Bakiny has no position in any of the stocks mentioned. The Motley Fool has positions ...
Finding a good laptop under $500 is no easy task. Just type “laptops under $500” into any search bar and you’ll be inundated with loads of results. Although you’ll see many options ...
These leaders shaping the future of business are on the fast track to becoming the next generation of Fortune 500 CEOs. After one of its toughest years ever, Nike brought back Hill, a beloved ...
All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. When shopping for a ...
S&P 500 index funds like VFIAX and SWPPX can be an easy and inexpensive way to round out most investment portfolios. Many, or all, of the products featured on this page are from our advertising ...